John Maki;Newell Bascomb;Fredric Young;Timothy J. Turner
发明人:
John Maki,Newell Bascomb,Timothy J. Turner,Fredric Young
申请号：
US13979362
公开号：
US20140031310A1
申请日:
2012.01.18
申请国别(地区):
US
年份:
2014
代理人:
摘要：
In alternative embodiments the invention provides compositions, e.g., pharmaceutical compositions and preparations, formulations, kits and other products of manufacture, e.g., exemplary drug combinations packaged together or separately in blister packs, lidded blisters or blister cards, or wrapped in paper, plastic or cellophane wrappers (e.g., a shrink wrap), comprising combinations of beneficial ingredients that in alternative embodiments are serviceable as therapies or palliatives for treating, preventing or improving conditions, states and disease symptoms involving the use of targeted protein kinase inhibitors such as Multi-Kinase Inhibitors (MKIs) or Epidermal Growth Factor Receptor (EGFR) Inhibitors (EGFRIs), or the use of other oral oncolytics, such as capcitabine or erlotinib, known to be associated with drug-induced dermatological toxicity, e.g., in the amelioration or treatment of a cancer, a dermatitis, a rosacea, an eczema, an ichthyosis, or a related condition； and methods for making and using these compositions； and methods for making and using these compositions.
